IRIS UniCatt

Pierconti, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.969
EU - Europa 3.738
AS - Asia 3.040
SA - Sud America 737
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
AN - Antartide 1
Totale 11.606
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.853
SG - Singapore 1.398
IT - Italia 1.061
CN - Cina 785
SE - Svezia 679
DE - Germania 660
BR - Brasile 618
PL - Polonia 304
FR - Francia 209
UA - Ucraina 174
VN - Vietnam 171
IN - India 166
IE - Irlanda 148
GB - Regno Unito 147
ID - Indonesia 117
FI - Finlandia 77
RU - Federazione Russa 77
JP - Giappone 65
TR - Turchia 61
CA - Canada 56
NL - Olanda 52
AR - Argentina 47
BD - Bangladesh 47
HK - Hong Kong 44
MX - Messico 37
BE - Belgio 33
ZA - Sudafrica 31
AT - Austria 26
KR - Corea 26
ES - Italia 24
IQ - Iraq 22
EC - Ecuador 20
CI - Costa d'Avorio 18
IR - Iran 17
MA - Marocco 17
VE - Venezuela 16
PK - Pakistan 15
UZ - Uzbekistan 14
CO - Colombia 13
CH - Svizzera 12
JO - Giordania 10
LT - Lituania 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
KE - Kenya 7
UY - Uruguay 7
LV - Lettonia 6
NO - Norvegia 6
NP - Nepal 6
PE - Perù 6
PH - Filippine 6
PY - Paraguay 6
AU - Australia 5
EG - Egitto 5
ET - Etiopia 5
NI - Nicaragua 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LB - Libano 4
LK - Sri Lanka 4
MD - Moldavia 4
OM - Oman 4
RO - Romania 4
SN - Senegal 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
MM - Myanmar 3
NG - Nigeria 3
PT - Portogallo 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
Totale 11.589
Salva come PNG Salva come JPEG
Città #
Singapore 690
Chandler 570
Ashburn 419
Warsaw 284
Beijing 172
Dublin 146
Milan 136
Rome 129
Ann Arbor 127
Los Angeles 122
Fairfield 117
New York 116
San Mateo 111
Wilmington 105
Jacksonville 104
Jakarta 102
Nanjing 94
Seattle 94
Houston 74
Chicago 71
Woodbridge 66
Munich 64
Frankfurt am Main 62
Hefei 62
São Paulo 62
The Dalles 62
Ho Chi Minh City 61
Dearborn 59
Boston 58
Hyderabad 57
Moscow 57
Princeton 52
Hong Kong 43
Redmond 43
Izmir 42
Hanoi 41
Bremen 40
Nanchang 36
Dallas 35
Marseille 34
Cattolica 31
Stockholm 31
Tokyo 31
Helsinki 29
Brussels 28
Kadoma 28
Lawrence 28
Cambridge 26
Santa Clara 26
Verona 26
Nürnberg 24
Seoul 23
Naples 22
Orem 22
Belo Horizonte 21
Bologna 21
Buffalo 21
Johannesburg 21
Kent 21
Redwood City 21
Denver 20
Florence 20
Shenyang 19
Abidjan 18
Bari 18
Enterprise 18
Montreal 18
Mountain View 18
Düsseldorf 17
Kunming 17
London 17
Toronto 17
Brasília 16
Hangzhou 16
Nuremberg 16
Shanghai 16
Vienna 16
Catania 15
Palermo 15
Tianjin 15
Brooklyn 14
Dhaka 14
Phoenix 14
Chennai 13
Falls Church 13
Guangzhou 13
Hebei 13
Miami 13
Poplar 13
Rio de Janeiro 13
Augusta 12
Boardman 12
Curitiba 12
Jiaxing 12
Kraków 12
Lauterbourg 12
Manchester 12
Mumbai 12
Tashkent 12
Genoa 11
Totale 5.914
Salva come PNG Salva come JPEG
Nome #
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 854
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 395
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 285
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 246
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 238
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 207
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 181
Incidental finding of right renal venous aneurysm in a patient with symptomatic ipsilateral renal carcinoma: a case report 179
Metabolic reprogramming by malat1 depletion in prostate cancer 172
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 171
MECKEL'S DIVERTICULUM FINDINGS ON TC-99 RED BLOOD SCINTIGRAPHY IN A BLEEDING LEUKEMIC PATIENT CONFIRMED BY TC-99 PERTENECHTATE SCINTIGRAPHY 159
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 157
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 156
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 156
Bladder and prostate metastasis from small cell lung cancer: a rare entity 147
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 135
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 134
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 134
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 133
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 133
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 129
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 126
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 126
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 123
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. 120
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 115
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 114
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 113
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 112
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 110
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 110
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma 110
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 109
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 109
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 108
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 107
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 105
Methylation study of the Paris system for reporting urinary (TPS) categories 105
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 104
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 103
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma. 103
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 102
Olfactory receptors in semen and in the male tract: From proteome to proteins 102
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 102
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 101
Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology 100
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 99
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 99
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 98
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy) 97
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 96
Biomarkers of response to advanced prostate cancer therapy 96
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 95
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making 95
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 94
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 93
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 92
Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy 90
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 90
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 90
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 90
Giant spermatic cord liposarcoma 88
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 88
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 87
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 86
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 86
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 86
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 85
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 83
p53 expression in cytology samples may represent a marker of early-stage cancer 83
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 83
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 82
Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario. 81
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 80
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 79
Proteomics for the identification of biomarkers in testicular cancer–review 79
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 78
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 78
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 77
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 77
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 76
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 75
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 75
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 74
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 72
Mesenchymal differentiation of glioblastoma stem cells 72
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 71
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 71
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 70
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 66
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma 66
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 65
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 64
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 64
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 64
Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications 64
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 62
Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B-cell lymphoma: A case report 61
First-line ICIs in renal cell carcinoma 53
Mesenchymal differentiation of glioblastoma stem cells 51
Totale 11.556
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 0 0 58 47 13 68 43 123 18
2021/2022860 76 39 27 80 70 28 38 125 41 57 131 148
2022/20231.769 249 232 139 261 92 210 84 130 179 69 83 41
2023/20241.194 79 227 62 75 89 158 93 61 24 84 104 138
2024/20252.177 70 61 196 94 175 128 75 101 243 247 448 339
2025/20263.114 743 187 313 690 969 212 0 0 0 0 0 0
Totale 11.786